# Phase 2 Trial of Ipilimumab and Nivolumab in Nasopharyngeal Carcinoma

> clinical trial · VERIFIED · 2026-06-22

Status: ACTIVE_NOT_RECRUITING · Sponsor: National Cancer Centre, Singapore · Condition: Nasopharyngeal Carcinoma

- Company: National Cancer Centre, Singapore
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT03097939

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.